Keros Therapeutics, Inc.
KROS
24 insider filings · Latest: Jun 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Jun 17 8:55 PM | Jean Jacques BienaimeDirector | Purchase | 1,000 | $10.19 | $10.2K | 17,592(D) | View → |
| Jun 11, 2026 | Jun 15 8:15 PM | Charles W. NewtonDirector | Sale | 550 | $10.04 | $5.5K | 12,665(D) | View → |
| Jun 11, 2026 | Jun 11 8:15 PM | Newton Charles W. | Proposed Sale | 550 | $9.95 | $5.5K | — | View → |
| Jun 4, 2026 | Jun 8 8:37 PM | Nima FarzanDirector | Sale | 2,625 | $10.73 | $28.2K | 9,767(D) | View → |
| Jun 4, 2026 | Jun 8 8:36 PM | Julius KnowlesDirector | Sale | 2,625 | $10.73 | $28.2K | 10,958(D) | View → |
| Jun 4, 2026 | Jun 5 8:15 PM | Alpna SethDirector | Sale | 2,625 | $10.72 | $28.1K | 9,767(D) | View → |
| Jun 4, 2026 | Jun 4 8:11 PM | Farzan Nima | Proposed Sale | 2,625 | $10.68 | $28.0K | — | View → |
| Jun 4, 2026 | Jun 4 8:09 PM | Knowles Julius | Proposed Sale | 2,625 | $10.68 | $28.0K | — | View → |
| Jun 4, 2026 | Jun 4 8:07 PM | Seth Alpna | Proposed Sale | 2,625 | $10.68 | $28.0K | — | View → |
| May 15, 2026 | May 19 8:15 PM | Jean Jacques BienaimeDirector | Purchase | 1,000 | $10.58 | $10.6K | 9,450(D) | View → |
| Apr 15, 2026 | Apr 17 8:15 PM | Jean Jacques BienaimeDirector | Purchase | 1,000 | $11.70 | $11.7K | 8,450(D) | View → |
| Mar 31, 2026 | Apr 1 1:57 AM | OrbiMed Genesis Master Fund, LP | Proposed Sale | 45,057 | $11.04 | $497.4K | — | View → |
| Mar 9, 2026 | Mar 11 8:33 PM | Jean Jacques BienaimeDirector | Purchase | 2,000 | $11.21 | $22.4K | 7,450(D) | View → |
| Feb 19, 2026 | Feb 20 9:15 PM | Jasbir SeehraDirector, CHIEF EXECUTIVE OFFICER | Sale | 7,015 | $16.17 | $113.4K | 385,708(D) | View → |
| Feb 18, 2026 | Feb 20 9:15 PM | Lorena Raquel LernerChief Science Officer | Sale | 3,873 | $16.35 | $63.3K | 31,127(D) | View → |
| Feb 18, 2026 | Feb 20 9:15 PM | Esther ChoSVP, General Counsel | Sale | 4,745 | $16.35 | $77.6K | 39,755(D) | View → |
| Feb 18, 2026 | Feb 20 9:15 PM | Keith RegnanteCHIEF FINANCIAL OFFICER | Sale | 4,739 | $16.35 | $77.5K | 39,261(D) | View → |
| Sep 12, 2025 | Sep 12 8:45 PM | Rovaldi Christopher | Proposed Sale | 85,306 | $15.71 | $1.3M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | Jun 5 9:20 PM | Alpna SethDirector | Grant/Award | 7,433 | $10.50 | 7,433(D) | View → |
| Jun 3, 2026 | Jun 5 8:15 PM | Mary Ann GrayDirector | Grant/Award | 7,433 | $10.50 | 7,433(D) | View → |
| Jun 3, 2026 | Jun 5 8:15 PM | Nima FarzanDirector | Grant/Award | 7,433 | $10.50 | 7,433(D) | View → |
| Jun 3, 2026 | Jun 5 8:15 PM | Jean Jacques BienaimeDirector | Grant/Award | 7,433 | $10.50 | 7,433(D) | View → |
| Jun 3, 2026 | Jun 5 8:15 PM | Julius KnowlesDirector | Grant/Award | 7,433 | $10.50 | 7,433(D) | View → |
| Apr 2, 2026 | Apr 6 8:15 PM | Jasbir SeehraDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 55,000 | $0.30 | 197,444(D) | View → |
| Feb 24, 2026 | Mar 27 8:15 PM | Esther ChoChief Legal Officer | Grant/Award | 80,000 | $15.52 | 80,000(D) | View → |
| Mar 9, 2026 | Mar 11 8:39 PM | Charles W. NewtonDirector | Grant/Award | 14,788 | $11.35 | 14,788(D) | View → |
| Feb 24, 2026 | Feb 26 9:15 PM | Jasbir SeehraDirector, CHIEF EXECUTIVE OFFICER | Grant/Award | 317,000 | $15.52 | 100,000(D) | View → |
| Feb 24, 2026 | Feb 26 9:15 PM | Keith RegnanteCHIEF FINANCIAL OFFICER | Grant/Award | 60,000 | $15.52 | 60,000(D) | View → |
| Feb 24, 2026 | Feb 26 9:15 PM | Esther ChoChief Legal Officer | Grant/Award | 80,000 | $15.52 | 80,000(D) | View → |
| Feb 24, 2026 | Feb 26 9:15 PM | Lorena Raquel LernerChief Scientific Officer | Grant/Award | 75,000 | $15.52 | 75,000(D) | View → |